Jpmorgan Chase & CO Elevance Health, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Elevance Health, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,523,988 shares of ELV stock, worth $924 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
2,523,988
Previous 2,381,846
5.97%
Holding current value
$924 Million
Previous $1.29 Billion
1.69%
% of portfolio
0.11%
Previous 0.11%
Shares
14 transactions
Others Institutions Holding ELV
# of Institutions
1,861Shares Held
197MCall Options Held
1.03MPut Options Held
1.24M-
Vanguard Group Inc Valley Forge, PA21.3MShares$7.81 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY20.7MShares$7.58 Billion0.26% of portfolio
-
State Street Corp Boston, MA10.7MShares$3.91 Billion0.23% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.2MShares$3.72 Billion0.61% of portfolio
-
Geode Capital Management, LLC Boston, MA4.85MShares$1.77 Billion0.21% of portfolio
About Elevance Health, Inc.
- Ticker ELV
- Exchange NYSE
- Sector Healthcare
- Industry Healthcare Plans
- Shares Outstandng 240,000,992
- Market Cap $87.8B
- Description
- Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....